News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Projects Launched to Crack the Cancer Code
The ICR is leading a project to create the most comprehensive genetic map of prostate cancer yet assembled, which will transform our understanding of the disease and pave the way to better and more targeted treatments. A second project aims to identify genetic faults driving oesophageal cancer.
Physicists Team up to Focus on Cancer
Scientists from leading London research centres met this week to discuss new ways to help cancer patients by combining their strengths in physics, clinical activities and basic research.
Scientists Unlock Further Prostate Cancer Secrets
Researchers at the ICR and University of Cambridge led an international study that discovered seven new variants in the human genome that increase the chances of developing prostate cancer.
New Line of Attack in Fight Against Cancer
Scientists have uncovered a new way of killing cancer cells, opening up a potentially highly effective avenue of attack in the fight against all forms of the disease.
Chemotherapy Protocol Proves Worth for High Risk Children’s Cancer
An 18 country Europe-wide study has demonstrated the benefit of the new European high dose chemotherapy protocol. The research was led by the ICR, The Royal Marsden and Great Ormond Street Hospital in the UK, and international collaborators.
Expert Independent Panel Reviews Mobile Phone Link to Brain Tumours
Accumulating scientific research is increasingly against the theory that mobile phone use causes brain tumours, an expert panel led by the ICR's Professor Tony Swerdlow has found.
Breast Cancer Patients Could Benefit from Fewer Radiotherapy Treatments
A major new clinical trial coordinated by the ICR will determine whether people diagnosed with breast cancer could benefit from receiving fewer radiotherapy treatments than the current UK standard.
Stem Cell Time Bombs Cause Leukaemia Relapse
Leukaemia “stem cells” can lie dormant in the body for a decade or more after a child achieves remission before being reactivated and causing a relapse, a new study shows.
Simple Blood Test Could Speed up Cancer Drug Development
Cancer drug development could accelerate in the future thanks to a simple and quick blood test that can help reveal the effectiveness of a new treatment, according to research presented this week at the ASCO annual meeting in Chicago.
New ‘Smart’ Pill Shown to Extend Lives of Patients with Most Aggressive Skin Cancer
The Institute of Cancer Research (ICR) was responsible for key research on the BRAF gene, which paved the way for the development of this first-of-its-kind personalised treatment for advanced melanoma.
ICR Scientist to Receive £2.14m Share of Inaugural Wellcome Trust Investigator Awards
Professor Dale Wigley of The Institute of Cancer Research (ICR) has been announced as a recipient of one of the inaugural Wellcome Trust Investigator Awards.
Gene Test Predicts Leukaemia Survival
Scientists at The Institute of Cancer Research (ICR) have found that a genetic test can be used to identify patients with the most common type of adult leukaemia who will not respond well to currently available drugs and should instead be considered for experimental treatments.
